Water-jet surgical robot
Waterjet technology for surgery has been around for some time, yet Procept is already having a successful complete prostate system around it:
"PROCEPT BioRobotics is a privately held medical device company
based in the heart of Silicon Valley developing a novel minimally
invasive technology for the surgical treatment of prostate disease.
PROCEPT’s AquaBeam
combines image guidance and robotics to deliver Aquablation, a waterjet
ablation therapy that enables targeted, controlled, and heat-free
removal of tissue for the treatment of lower urinary tract symptoms as a
result of benign prostatic hyperplasia (BPH).
The AquaBeam system is
a first of its kind image-guided system delivering a treatment
utilizing water and robotics for the targeted removal of prostate
tissue. AquaBeam combines
image guidance and robotics to deliver Aquablation, a personalized
waterjet tissue resection modality. Under real-time image-based
ultrasonic guidance, AquaBeam
enables surgical planning and mapping, and allows for a controlled
resection of the prostate with a high-velocity saline stream. The
combination of surgical mapping and controlled resection of the prostate
is designed to offer predictable and reproducible outcomes.
The WATER study (Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue) is a prospective randomized U.S. investigational
device exemption (IDE) clinical trial evaluating the safety and
effectiveness of the AquaBeam
System as compared to the current standard of care, transurethral
resection of the prostate, or TURP. The WATER study will enroll over 200
male patients between the ages of 45 and 80 years old who have urinary
symptoms due to BPH.
The study will be recruiting patients in 20 global sites including
sites in the United States, Europe, Australia and New Zealand."
Comments